Background Best current estimates of neuropathic pain (NeuP) prevalence come from studies using various screening detecting pain with probable neuropathic features; the proportion experiencing ...

With over 10 million people affected worldwide, Parkinson's disease is the fastest-growing neurological disorder. More than ...

With FDA fast track and breakthrough therapy designations already secured for the drug to treat acute pain, Vertex is now focusing on neuropathic ... numeric pain rating scale (NPRS) assessed ...

which compared AP-325 to placebo in people with post-surgical neuropathic pain, the drug achieved a significant and "clinically meaningful" reduction in the Pain Intensity Numeric Rating Scale (PI ...

Vertex Pharma's non-opioid painkiller suzetrigine was unable to perform better than placebo in a phase 2 trial in lumbosacral radiculopathy (LSR), a form of neuropathic back pain, ahead of an FDA ...

hypothesized that a similar mechanism underlies persistent neuropathic pain ... correlated with reported pain intensity as measured by a visual analog scale. In addition, the region that ...